Silo Pharma (SILO) Cash from Operations (2010 - 2026)
Silo Pharma (SILO) posted Cash from Operations of 822623.0 for Q1 2026, down 5.43% sequentially from 780278.0 in Q4 2025, and up 49.85% YoY from 548967.1 in Q1 2025.
Silo Pharma (SILO) Cash from Operations (2010 - 2026) Analysis & Trends
Silo Pharma has reported Cash from Operations for 14 years, with the latest figure at 822623.0 in Q1 2026.
- Quarterly Cash from Operations rose 49.85% year-over-year to 822623.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 3843662.0 (up 17.09% YoY) and the FY2025 annual result came in at 4661339.0, down 21.58% from the prior year.
- Cash from Operations slipped to 822623.0 in Q1 2026 per SILO's latest filing, from 780278.0 in the prior quarter.
- Over five years, Cash from Operations peaked at 400109.0 in Q2 2022 and troughed at 1640300.0 in Q1 2025.
- A 5-year average of 943529.18 and a median of 885989.0 in 2022 frame the typical range for Cash from Operations.
- The sharpest annual moves came in 2022 and 2026: Cash from Operations plunged 147.14% in 2022, then jumped 49.85% in 2026.
- Over 5 years, Cash from Operations stood at 885989.0 in 2022, then fell by 2.71% to 910012.0 in 2023, then retreated by 0.82% to 917432.0 in 2024, then increased by 14.95% to 780278.0 in 2025, then slipped by 5.43% to 822623.0 in 2026.
- According to Business Quant data, Cash from Operations over the past three periods registered 822623.0, 780278.0, and 955493.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 1.13 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 813.00 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -526.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 462.82 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 326.72 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 360.27 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -88.83 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 728.46 Mn |
| 10 | Silo Pharma | 2.92 Mn | 2.92 Mn | - | -781,861.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -781,861.00 |
| Jun 30, 2026 | -781,861.00 |
| Mar 31, 2026 | -822,623.00 |
| Mar 31, 2026 | -822,623.00 |
| Dec 31, 2025 | -780,278.00 |
| Dec 31, 2025 | -780,278.00 |
| Sep 30, 2025 | -955,493.00 |
| Sep 30, 2025 | -955,493.00 |
| Jun 30, 2025 | -1.29 Mn |
| Jun 30, 2025 | -1.29 Mn |
| Mar 31, 2025 | -1.64 Mn |
| Mar 31, 2025 | -1.64 Mn |
| Dec 31, 2024 | -917,432.00 |
| Dec 31, 2024 | -917,432.00 |
| Sep 30, 2024 | -1.35 Mn |
| Sep 30, 2024 | -1.35 Mn |
| Jun 30, 2024 | -731,803.00 |
| Jun 30, 2024 | -731,803.00 |
| Mar 31, 2024 | -838,179.00 |
| Mar 31, 2024 | -838,179.00 |